Basal activation of ERK1/2 blunts the antimicrobial activity of neutrophils from aged hosts against antibody opsonized Streptococcus pneumoniae
Abstract
The decline in neutrophil antimicrobial function renders vaccinated aged hosts less protected against Streptococcus pneumoniae infection. In vaccinated hosts, activation of neutrophils via phagocytic receptors, like complement and Fc{gamma} receptors, mediates bacterial uptake and killing. However, the mechanisms behind changes in signaling downstream of these receptors with age is not known. Mitogen-activated protein kinases (MAPK) are signaling cascades activated in response to cell surface receptors. Using bone marrow neutrophils isolated from young and aged mice, and MAPK phosphorylation array, we found differences in MAPK activation in an opsonin dependent manner (complement vs antibody). Neutrophils from aged mice failed to increase MAPK phosphorylation upon infection with pneumococci opsonized with heat-inactivated (HI) sera from hosts immunized with the pneumococcal conjugate vaccine (PCV), indicating an age-related defect in Fc{gamma}R signaling. Neutrophils from aged mice had higher basal levels of MAPK phosphorylation when compared to young controls, including a 15-fold increase in ERK1/2 phosphorylation. Inhibition of ERK1/2 signaling blunted pneumococcal killing by PMNs from young mice, but improved killing by neutrophils from aged mice, only when the bacteria were opsonized with HI immune but not naive sera. In young human participants, in vitro inhibition of ERK1/2 in neutrophils resulted in decreased pneumococcal killing, but only following PCV vaccination, suggesting that the effects of ERK1/2 inhibition are clinically relevant in vaccinated hosts. This study identifies age-related changes in ERK1/2 activation and demonstrates that balanced activation of this pathway is crucial for neutrophil antimicrobial activity against antibody opsonized bacteria following vaccination in both mice and humans. Summary sentenceImbalanced ERK1/2 activation impairs neutrophil activity in aged hosts. LEGENDS O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=134 SRC="FIGDIR/small/656427v1_ufig1.gif" ALT="Figure 1"> View larger version (21K): org.highwire.dtl.DTLVardef@179c31forg.highwire.dtl.DTLVardef@f95d4borg.highwire.dtl.DTLVardef@15c1dcborg.highwire.dtl.DTLVardef@a8076e_HPS_FORMAT_FIGEXP M_FIG C_FIG Graphical AbstractGraphic Abstract Created in BioRender. Bou Ghanem, E. (2025) https://BioRender.com/jjoodsu.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Adenosine 2B receptor signaling impairs vaccine-mediated protection against pneumococcal infection in young hosts by blunting neutrophil killing of antibody opsonized bacteria
Shaunna R. Simmons, Alexsandra P. Lenhard, … Elsa N. Bou Ghanem·VaccinesPeer-reviewed·Apr 15, 2025
- Activating A1 adenosine receptor signaling boosts early pulmonary neutrophil recruitment in aged mice in response to Streptococcus pneumoniae infection
Shaunna R. Simmons, Sydney E. Herring, … Elsa N. Bou Ghanem·Immunity & AgeingPeer-reviewed·Jun 5, 2024
- Extracellular adenosine signaling reverses the age-driven decline in the ability of neutrophils to kill S. pneumoniae
M. Bhalla, S. R. Simmons, … E. N. Bou Ghanem·bioRxiv·Apr 14, 2020
- Transcriptome profiling reveals CD73 and age-driven changes in neutrophil responses against Streptococcus pneumoniae
M. Bhalla, L. R. Heinzinger, … E. N. Bou Ghanem·bioRxiv·Apr 14, 2021
- A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity Upon Viral Infection and Advanced Age
B. J. Joma, N. Siwapornchai, … E. N. Bou Ghanem·bioRxiv·Jul 29, 2020
- Neutrophils are required during immunization with the pneumococcal conjugate vaccine for protective antibody responses and host defense against infection
E. Y. I. Tchalla, E. A. Wohlfert, E. N. Bou Ghanem·bioRxiv·Feb 4, 2020